EyRIS: From the lab to the market

Author

Steven MILLER, Singapore Management UniversityFollow
David GOMULYA, Singapore Management UniversityFollow
Mahima RAO-KACHROO, Singapore Management UniversityFollow

Publication Type

Magazine Article

Version

publishedVersion

Publication Date

3-2024

Abstract

Singapore’s trailblazer AI algorithm for detecting diabetes-related eye diseases. Can you imagine getting the results of your eye disease screening within minutes rather than days? This capability is what EyRIS, a Singapore-based start-up that uses the AI (Artificial Intelligence)-driven Singapore Eye LEsion Analyzer (SELENA+) algorithm to screen for diabetes-related eye diseases, set out to productise and commercialise.

Keywords

Artificial Intelligence, Singapore, healthcare, eye screening

Discipline

Artificial Intelligence and Robotics | Asian Studies | Health Information Technology

Research Areas

Information Systems and Management

Publication

Asian Management Insights (Singapore Management University)

Volume

11

Issue

1

First Page

46

Last Page

53

ISSN

2315-4284

Publisher

Singapore Management University, Centre for Management Practice

City or Country

Singapore

Embargo Period

4-8-2024

Citation

MILLER, Steven; GOMULYA, David; and RAO-KACHROO, Mahima. EyRIS: From the lab to the market. (2024). Asian Management Insights (Singapore Management University). 11, (1), 46-53.
Available at: https://ink.library.smu.edu.sg/ami/248

Copyright Owner and License

Singapore Management University

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-No Derivative Works 4.0 International License.

Additional URL

https://cmp.smu.edu.sg/ami/article/20240326/eyris-lab-market